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Specification of osteoblast cell fate by canonical Wnt signaling
requires Bmp2
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ABSTRACT
Enhanced BMP or canonical Wnt (cWnt) signaling are therapeutic
strategies employed to enhance bone formation and fracture
repair, but the mechanisms each pathway utilizes to specify cell
fate of bone-forming osteoblasts remain poorly understood. Among
all BMPs expressed in bone, we find that singular deficiency of
Bmp2 blocks the ability of cWnt signaling to specify osteoblasts
from limb bud or bone marrow progenitors. When exposed to
cWnts, Bmp2-deficient cells fail to progress through the Runx2/
Osx1 checkpoint and thus do not upregulate multiple genes
controlling mineral metabolism in osteoblasts. Cells lacking Bmp2
after induction of Osx1 differentiate normally in response to cWnts,
suggesting that pre-Osx1+ osteoprogenitors are an essential
source and a target of BMP2. Our analysis furthermore reveals
Grainyhead-like 3 (Grhl3) as a transcription factor in the osteoblast
gene regulatory network induced during bone development and
bone repair, which acts upstream of Osx1 in a BMP2-dependent
manner. The Runx2/Osx1 transition therefore receives crucial
regulatory inputs from BMP2 that are not compensated for by
cWnt signaling, and this is mediated at least in part by induction
and activation of Grhl3.
KEY WORDS: BMP, Wnt, Osteoblast, Osx1, Sp7, Dlx5, Grhl3, Mouse
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INTRODUCTION
Bone morphogenetic proteins (BMPs) and canonical Wnts (cWnts)
play essential roles in the skeleton. BMPs, originally identified for
their ability to induce de novo formation of bone and cartilage, are
secreted ligands that act through cell surface complexes comprised
of type I and type II BMP receptors to activate Smad1/5/8-
dependent gene transcription (Salazar et al., 2016). cWnts are
secreted proteins that signal through Lrp and Frizzled co-receptor
complexes to stabilize intracellular pools of β-catenin and activate
Tcf/Lef-dependent gene transcription (Baron and Kneissel, 2013).
Genetic mutations in either of these pathways underlie a variety of
severe skeletal pathologies including the high and low bone mass
syndromes associated with mutations of the cWnt receptor Lrp5
(Boyden et al., 2002; Gong et al., 2001; Little et al., 2002) or
fibrodysplasia ossificans progressiva, a disease characterized by
inappropriate growth of endochondral bone at non-skeletal sites and
caused by mutations of the type I BMP receptor ALK2 (Shore et al.,
2006). For over a decade, recombinant BMPs, particularly BMP2
and BMP7, have been used in clinical orthopedic settings including
non-union fractures, spinal fusions and oral surgery (Lo et al.,
2012). More recently, neutralizing antibodies targeting antagonists
of the cWnt pathway, such as SOST and DKK1, have entered
clinical trials as systemic agents that enhance bone formation (Baron
and Kneissel, 2013).
Given the abundance of information establishing clear roles for
BMP and cWnt signaling in bone development and disease, and the
fact that therapies based on each pathway are approved or under
evaluation for use in humans, it is somewhat remarkable that the
individual aspects of osteoblast specification and physiology
controlled by either BMP or cWnt signaling remain largely
undefined.
During development, bones of the appendicular skeleton are
made by a Prx1 (Prrx1)+ subset of cells that arise in lateral plate
mesoderm during limb bud outgrowth (Durland et al., 2008; Logan
et al., 2002). Postnatally, undifferentiated cells of the Prx1 lineage
persist in the marrow and periosteum of mature bone as distinct but
complementary pools of Lepr+ orGrem1+ osteoprogenitors that can
be activated by BMP2 for the purpose of bone growth or repair
(Chan et al., 2015; Worthley et al., 2015; Zhou et al., 2014). We
hypothesized that BMPs and cWnts play unique roles in specifying
Prx1+ progenitors to the osteoblast cell fate. To test this, we utilized
limb bud cells and bone marrow cells as models of Prx1+ cell
populations to monitor osteogenic responses to cWnt activity in the
presence or absence of Bmp2.
RESULTS
Bmp2 is required for limb bud cells to undergo osteoblast
differentiation in response to Wnt3a
Immortalized cells from the E13.5 mouse embryonic limb bud
(MLB13 cells) express endogenous Bmp2 and exhibit robust
endochondral differentiation in response to recombinant BMPs
(Rosen et al., 1993, 1994). We established a sub-clonal population
of MLB13 (MLB13WT) cells stably expressing siRNA against
endogenous Bmp2 (MLB13kdBmp2) (Fig. 1A). Osteoblast
differentiation was induced for 48 h by supplementing the cell
culture medium with ascorbic acid and β-glycerophosphate
(osteogenic medium) with or without recombinant (r)BMP2 or
Wnt3a. QPCR analysis revealed that levels of Prx1, Runx2 and
Dlx5 mRNA were unaffected by knockdown of Bmp2, while Osx1
(Sp7) and the direct transcriptional target of Osx1, Alpl (Hojo
et al., 2016), were dramatically diminished. Osx1 and Alpl
mRNAs could be enhanced in MLB13kdBmp2 cells by rBMP2 but
not rWnt3. Wnt3a furthermore significantly diminished Dlx5
mRNA in MLB13kdBmp2 but not MLB13WT cells (Fig. 1B-F).
MLB13kdBmp2 cells treated with Wnt3a retained the ability toReceived 18 March 2016; Accepted 7 October 2016
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upregulate the TCF/Lef target gene Axin2 (Fig. 1G). MLB13WT
cells exhibited a dose-dependent increase in ALP activity in
response to Wnt3a, whereas ALP activity in MLB13kdBmp2 cells
was ∼73% lower than MLB13WT cells grown in osteogenic
medium alone and remained unchanged by any concentration of
Wnt3a (Fig. 1H).
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Fig. 1. See next page for legend.
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Bmp2 is required for bone marrow stromal cells to form
osteoblasts and mineralize matrix in response to Wnt3a
We also examined Wnt-induced osteoblast differentiation of adult
bone marrow stromal cells (BMSCs) lacking Bmp2 expression.
BMSCs carrying a single copy of the TdTomatoFlox-stop-Flox reporter
allele were used to optimize a protocol for in vitro recombination
using Adeno-Cre. Fluorescence microcopy showed that nearly all
TdTomatoFlox-stop-Flox cells transduced with Adeno-Cre but none of
the cells transduced with Adeno-GFP were Tomato+ (Fig. 1I).
BMSCs carrying two floxed alleles of Bmp2 (Bmp2F/F) were
transduced with Adeno-GFP (Bmp2AdenoF/F) or Adeno-Cre
(Bmp2AdenoΔ/Δ), and osteoblast differentiation was induced with
osteogenic mediumwith or without BMP2 orWnt3a. After 10 days,
BMSCs were stained with alkaline phosphatase (ALP) substrate to
monitor induction of osteoblast differentiation and Alizarin Red dye
to visualize calcification of the extracellular matrix. ALP activity
and matrix calcification were comparable in Bmp2AdenoF/F and
Bmp2AdenoΔ/Δ cells grown in control osteogenic conditions,
enhanced in both genotypes of cells by rBMP2, and were greatest
in both genotypes of cells treated with BMP2 and Wnt3a. By
contrast, Wnt3a enhanced ALP activity and matrix calcification of
Bmp2AdenoF/F cells but not Bmp2AdenoΔ/Δ cells, which exhibited even
less osteoblast differentiation in response to Wnt3a than cells grown
in osteogenic medium alone (Fig. 1J). BMSCs were analyzed on
day 7 by QPCR to confirm recombination of Bmp2 (Fig. 1K) and
assess osteoblast markers. Similar to results obtained in limb bud
cells, mRNAs for Prx1 and Runx2 were not diminished by loss of
Bmp2, while Osx1 and two Osx1 target genes, Alpl and Col1a1
(Hojo et al., 2016), were significantly reduced in Bmp2AdenoΔ/Δ cells
exposed to Wnt3a (Fig. 1L-P).
Canonical Wnt signaling does not compensate for selective
ablation of Bmp2 in Prx1+ cells
Prx1-Cre was used to conditionally delete Bmp2 in the limb bud
mesenchyme at E9.5 when endochondral progenitors of the
appendicular skeleton first appear during development (Durland
et al., 2008; Logan et al., 2002). Bmp2 was efficiently ablated by
endogenous expression of Prx1-Cre, was expressed in Bmp2F/F
BMSC and was upregulated by BMP2, Wnt3a and BMP2+Wnt3a
together (Zhang et al., 2013) (Fig. 2A). Osteoblast lineage markers
including Prx1, Runx2, Osx1, Alpl and Col1a1 were upregulated in
Bmp2F/F cells treated with BMP2 or Wnt3a, and most strongly
expressed in Bmp2F/F cells treated with BMP2 plus Wnt3a. These
genes were also upregulated in Bmp2Prx1Δ/Δ cells treated with BMP2
or BMP2 plus Wnt3a, to levels comparable to those in wild-type
(WT) cells grown under corresponding conditions. However, with
the exception of Prx1 and Runx2, Bmp2Prx1Δ/Δ cells treated with
Wnt3a did not upregulate the osteoblast differentiation markers
Osx1, Alpl andCol1a1 to similar levels as observed in Bmp2F/F cells
(Fig. 2B-F). BMSCs from Bmp2F/F or Bmp2Prx1Δ/Δ mice produced
comparable levels of calcified matrix (Fig. 2G,H) and immunoblot
analysis showed they expressed similar amounts of Osx1 protein
(Fig. 2I). BMP2 greatly enhanced matrix mineralization (Fig. 2G,H)
and the abundance of Osx1 in Bmp2F/F or Bmp2Prx1Δ/Δ cells
(Fig. 2I), confirming our in vivo observation that osteoprogenitors in
Bmp2Prx1Δ/Δ mice retain the ability to respond to exogenous BMP2
(Chappuis et al., 2012). In stark contrast, Wnt3a greatly enhanced
the amount of mineralized matrix and Osx1 protein produced by
WT cells but not by Bmp2Prx1Δ/Δ cells (Fig. 2G-I), which made even
less mineralized matrix and Osx1 protein than Bmp2Prx1Δ/Δ cells
grown in osteogenic medium alone (Fig. 2G, control). Concomitant
treatment of cells with both BMP2 and Wnt3a also induced robust
mineralization and Osx1 expression (Fig. 2G-I). Notably, this
response was indistinguishable between WT and Bmp2Prx1Δ/Δ cells,
indicating that the ability of Bmp2Prx1Δ/Δ cells to upregulate Osx1
and make calcified matrix in the presence of Wnt3a is fully rescued
by exogenous BMP2. The Osx1 banding pattern in cells treated with
BMP2 and/or Wnt3a was complex, with the appearance of several
slower-migrating bands, suggesting that Osx1 undergoes post-
translational modifications in differentiating osteoblasts, as seen
with other Sp transcription factor family members (Waby et al.,
2008). Regardless of culture supplements, Bmp2Prx1Δ/ΔBMSCs had
reduced levels of phosphorylated Smad1/5 but similar levels of
phosphorylated Smad2/3 compared with Bmp2F/F BMSCs,
suggesting that total BMP signaling was reduced while TGF-β/
activin signaling remained unchanged (Fig. 2I).
Bmp2-deficient cells are able to activate Tcf/Lef-dependent
transcription
We further examined the possibility that diminished osteogenic
response of Bmp2Prx1Δ/Δ cells to Wnt3a can be explained by an
inability of Bmp2-deficient cells to activate Tcf/Lef activity.
Immunoblots revealed that β-catenin, an essential transcriptional
mediator of cWnt signaling, was modestly reduced in Bmp2Prx1Δ/Δ
cells and markedly diminished in Bmp2Prx1Δ/Δ cells treated with
Wnt3a (Fig. S1A). QPCR showed that mRNAs encoding essential
signaling molecules of the cWnt pathway are expressed in
Bmp2Prx1Δ/Δ cells grown in osteogenic medium with or without
Wnt3a (Fig. S1B), as well as Bmp2AdenoΔ/Δ cells grown in osteogenic
medium with or without Wnt3a (Fig. S1C), suggesting that the
diminished amounts of β-catenin protein detected in Bmp2Prx1Δ/Δ
cells grown with or without Wnt3a (Fig. S1A) occurs via a post-
transcriptional mechanism. Despite diminished protein levels of
β-catenin in Bmp2Prx1Δ/Δ cells, the Tcf/Lef-target gene Axin2 (Jho
et al., 2002)was strongly upregulated inBmp2Prx1Δ/Δ cells (Fig. S2B)
or Bmp2AdenoΔ/Δ cells following exposure to Wnt3a (Fig. S2C),
similar to previous results obtained in MLB13 cells (Fig. 1G).
Wnt3a induces a different transcriptome in Bmp2F/F and
Bmp2; Prx1-Cre cells
We next performed comparative transcriptome-level gene
expression analysis. BMSCs from Bmp2F/F or Bmp2Prx1Δ/Δ mice
were differentiated with osteogenic medium alone, BMP2, Wnt3a
or BMP2+Wnt3a. RNA was harvested on day 7 to generate 24
samples. All 24 samples were used to prepare cDNA for traditional
QPCR analysis. A subset of samples was also used to make cDNA
Fig. 1. Lack of Bmp2 in limb bud or bone marrow stromal cells blocks
osteoblast differentiation in response toWnt3a. (A-H) Immortalized mouse
limb bud cells from E13.5 embryos (MLB13WT cells) were transfected with
plasmid-based shRNA to establish a clonal population of cells with stable
knockdown of Bmp2 (MLB13kdBmp2 cells). (A-G) QPCR, expressed as mean
fold change relative to MLB13WT cells. N=3 biological replicates, *P<0.05.
(H) Alkaline phosphatase activity in MLB13 cells cultured for 48 h with
increasing concentrations of Wnt3a. N=3 biological replicates; *P<0.05 vs
control MLB13kdBmp2 cells. #P<0.05 vs control MLB13WT cells. (I) Primary bone
marrow stromal cells (BMSCs) from TdTomatoflox-stop-flox/+ mice were
transduced with Adeno-GFP or Adeno-Cre. The efficiency of transduction and
recombination was visualized by DAPI and RFP filters (10×, fluorescence).
(J-P) BMSCs from Bmp2F/Fmice were transduced with Adeno-GFP or Adeno-
Cre and differentiated in osteogenic medium (OM) plus recombinant growth
factors. (J) Alkaline phosphatase activity (blue) and matrix calcification (red)
was assessed by biochemical staining on day 10 (2.5×, brightfield, with
1× inset). (K-P) QPCR analysis, expressed as mean fold change relative to
Bmp2F/F+Adeno-Cre cells grown in osteogenic medium alone. Error bars
represent s.d. of two independent experiments.
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libraries for microarray analysis: (1) one pooled sample of Bmp2F/F
extracts (n=3); (2) three unpooled samples of Bmp2F/F+Wnt3a
extracts; (3) three unpooled samples Bmp2Prx1Δ/Δ+Wnt3a extracts;
and (4) one pooled sample of Bmp2Prx1Δ/Δ cells treated with
BMP2+Wnt3a (n=3). All eight samples performed as a single tissue
type (Fig. S2A), had similar gene-level mean signal intensities
after normalization and summarization using Expression Console
(Fig. S2B) and produced a >2-fold signal to background ratio
O
M
B
M
P
2
W
nt
3a
B
M
P
2+
W
nt
3a O
M
B
M
P
2
W
nt
3a
B
M
P
2+
W
nt
3a
O
M
B
M
P
2
W
nt
3a
B
M
P
2+
W
nt
3a O
M
B
M
P
2
W
nt
3a
B
M
P
2+
W
nt
3a
** * *
O
M
B
M
P
2
W
nt
3a
B
M
P
2+
W
nt
3aO
M
B
M
P
2
W
nt
3a
B
M
P
2+
W
nt
3a
0
100
200
300
400
500
600
700
800
900
1000
C
on
tro
l
B
M
P
2
O
st
eo
ge
ni
c 
M
ed
iu
m
 
W
nt
3a
B
M
P
2 
+ 
W
nt
3a
Bmp2F/F
G
H
Control BMP2 Wnt3a BMP2+ 
Wnt3a
A
liz
ar
in
 R
ed
 (m
M
)
Bmp2F/F
Bmp2PrxΔ/Δ
*
5 5 3 3 3 5 4 4
*
#
#
#
n
n.s.
n.s.
pSmad1/564
64
pSmad2/3
Bmp2F/F; Prx1-Cre
WT cKO WT cKO WT cKO WT cKO
kDa Osx1
50
-Tubulin60
Control BMP2 Wnt3a BMP2+
Wnt3a
I
1.00 0.87 1.08 0.75 0.80 0.52 0.54 0.31 pSmad1/5 vs. Tubulin
0
2
4
6
8
10
12
14
16
18
20 Bmp2
A
-99%
0
1
2
3
4
5 Prx1
m
R
N
A
 (f
ol
d 
ch
an
ge
)
0
2
4
6
8 Runx2
m
R
N
A
 (f
ol
d 
ch
an
ge
)
0
5
10
15
20
25 Osx1
m
R
N
A
 (f
ol
d 
ch
an
ge
)
0
5
10
15
20
25 Alpl
m
R
N
A
 (f
ol
d 
ch
an
ge
)
0
20
40
60
80
100 Col1a1
m
R
N
A
 (f
ol
d 
ch
an
ge
)
Bmp2 F/F
Bmp2PrxΔ/Δ
B
*
n.s.
n.s.
0.01
0.01
n.s. n.s
n.s.
0.03
n.s.
1E-3
n.s.
7E-6
n.s.
7E-4
n.s.
n.s.
n.s.
3E-3
n.s.
m
R
N
A
 (f
ol
d 
ch
an
ge
)
C D
E F
2E-5
3E-3
8E-4 0.01
1E-4
3E-3
1E-4
3E-3
1E-4
1E-3
0.02
5E-4
4E-4
8E-4
2E-4 8E-4
0.02
3E-6
Bmp2Prx1Δ/Δ
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(Fig. S2C). Pearson’s correlation analysis demonstrated that the four
sample types segregated into four distinct groups according to
genotype and treatment (Fig. S2D).
Gene expression was calculated as linear fold change in Bmp2F/F
relative to Bmp2Prx1Δ/Δ cells treated with Wnt3a. When the top
5000 most differentially regulated genes were used to perform
hierarchical cluster analysis, samples from Bmp2F/F or Bmp2Prx1Δ/Δ
cells treated with Wnt3a segregated into two distinct groups based
on genotype (Fig. 3A). A total of 165 genes were downregulated >2
fold in Bmp2F/F versus Bmp2Prx1Δ/Δ (blue datapoints, Fig. 3B) and
114 genes were upregulated >2 fold in Bmp2F/F versus Bmp2Prx1Δ/Δ
(red datapoints, Fig. 3B), where P<0.05. Differentially regulated
genes were widely distributed throughout the genome and every
chromosome (Fig. 3C).
The Runx2/Osx1 transition and induction of mineral
metabolism requires expressionofBmp2 in thePrx1+ lineage
and is not compensated for by cWnt signaling
We identified several pathways with ≥2 targets exhibiting ≥2-
fold change in expression and a P-value ≤0.05 (Fig. 3D).
Consistent with a study focused on cells lacking Bmp2, molecules
in the BMP pathway, including Bmp2, and transcriptional gene
targets of BMP signaling, including Smad6, Smad8, Id1 and Id3
(Table 1) were enriched. Intriguingly, the phenotype of
Bmp2Prx1Δ/Δ cells remains despite the fact that BMSC-derived
osteoblasts expressed ≥17 other BMP/GDF ligands, and a variety
of Type I and Type II BMP receptors that is sufficient to maintain
some BMP signaling (Table 1 and Fig. 2I). Several modulators of
Wnt signaling were altered in Bmp2Prx1Δ/Δ cells treated with
Wnt3a, including Lgr5, Lgr6, Wif1, Notum, and Sfrp2; however,
many established Tcf/Lef target genes, including Axin2 and Lef1,
were induced normally following exposure to Wnt3a, confirming
that cWnt signaling was functional in the absence of Bmp2
(Table 2). Consistent with the mesenchymal and stem/progenitor
cell nature of input samples, targets related to pluripotency,
endochondral ossification and adipogenesis pathways were
enriched (Fig. 3D) and included Lifr, FGFR2, Ihh, Ptch1,
Mef2c and Sox9 (Table 3). Bmp2Prx1Δ/Δ cells treated with Wnt3a
expressed early markers of endochondral lineages, but expressed
statistically low levels of Osx1, Dlx3 and Dlx5 (Table 3). A
variety of G-protein-coupled receptors with established roles in
osteoblasts were also enriched, including serotonin receptor type
2a (Htr2a) and Pthr1 (Pth1r). Bmp2Prx1Δ/Δ cells treated with
Wnt3a do not mineralize, and indeed these cells fail to induce
Alpl and Phospho1, which are both poly-phosphate-metabolizing
enzymes required during development for mineralization of the
skeleton (Yadav et al., 2011), and Dmp1, a glycoprotein involved
in bone/renal mineral homeostasis (Rowe, 2012) (Table 4).
BMSC-derived osteoblasts expressed all 15 members of the
carbonic anhydrase family – enzymes recently implicated in
production of precursors to mature calcium hydroxyapatite
crystals of vertebrate bone (Müller et al., 2013; Wang et al.,
2014); Bmp2Prx1Δ/Δ cells treated with Wnt3a expressed negligible
levels of both Car3 and Car12 (Table 4).
QPCR was used to validate selected genes identified by
microarray and furthermore evaluate their expression profiles in
cells treated with BMP2 or BMP2 plus Wnt3a. As previously
reported, Bmp2 and Bmp4 were upregulated by Wnt3a in Bmp2F/F
cells (Shu et al., 2005; Zhang et al., 2013) (Fig. 4A). Bmp2F/F and
Bmp2Prx1Δ/Δ cells expressed similar levels of early endochondral
lineage markers Prx1 and Runx2, but Bmp2Prx1Δ/Δ cells treated with
Wnt3a failed to acquire a committed osteoblast phenotype
characterized by increased expression of Osx1, Dlx3 and Dlx5
(Fig. 4B). Bmp2F/F and Bmp2Prx1Δ/Δ cells expressed similar levels of
Alpl and Phospho1, Car3, Car12 and Dmp1, but Bmp2Prx1Δ/Δ cells
treated with Wnt3a expressed only modest levels of these genes
(Fig. 4B). Expression of osteoblast markers and mineral metabolism
enzymes in Bmp2Prx1Δ/Δ cells treated with Wnt3a could be rescued
by complementation with exogenous BMP2 (Fig. 4B,C). In this
experiment, the fundamental finding that Bmp2-deficient cells
exhibit impaired progression to the Osx1/Dlx5+ cell fate phenotype
in response to Wnt3a was clear; however, some responses to BMP2
were blunted, presumably as a result of a weak batch of BMP2. We
therefore cultured primary BMSCs one more time, and used QPCR
to verify that Bmp2Prx1Δ/Δ cells are unable to induce Osx1 in
response to Wnt3 without complementation by exogenous BMP2
(Fig. 4D). These samples were used to proceed with analysis of
Grhl3, one of the most highly altered genes identified by
comparative microarray analysis on Bmp2Prx1Δ/Δ cells treated with
Wnt3a.
Grhl3 encodes a transcription factor not previously recognized to
play a role in osteoblast cell fate specification. In BMSCs, Grhl3
expression was induced byWnt3a >50-fold in Bmp2Prx1Δ/Δ cells and
>117-fold in Bmp2F/F cells.Grhl3 expression was not induced at the
mRNA level by BMP2 alone, but was maximally induced (>300-
fold) regardless of genotype in BMSCs co-stimulated with BMP2
and Wnt3a (Fig. 4E). In MLB13 cells, Grhl3 mRNA was
diminished by knockdown of Bmp2, and enhanced by Wnt3a
regardless of the Bmp2 genotype (Fig. 4F). The USCS Genome
Browser (Kent et al., 2002) was used to examine the genetic locus of
murine Grhl3 (Fig. S3A) and revealed two consensus Tcf/Lef-
binding sites (Cadigan and Waterman, 2012; Frietze et al., 2012;
Guenther et al., 2014) in regions of high to medium genomic
conservation in vertebrates (Fig. S3B,C). Compared with MLB13
cells expressing plasmid-derived EGFP, Grhl3 mRNA was
increased 12 h after transfection by a plasmid encoding Wnt1, but
not by a plasmid encoding Wnt5. Grhl3 was also induced by 4 h of
treatment with recombinant Wnt3a, and this induction was not
sensitive to increasing titrations of cycloheximide (25-100 µg/ml),
suggesting that protein translation is not required for Grhl3
induction by cWnt signaling (Fig. 4G) and that Grhl3 is a direct
canonical Wnt target gene.
Bmp2 is dispensable after acquisition of Osx1+ cell fate for
osteoblast differentiation and mineralization
To examine the relevance of our microarray analysis, we first tested
the model that Bmp2 is required at the Runx2/Osx1 transition during
Wnt-activated differentiation of osteoblasts. Mice were bred to
conditionally ablateBmp2 in committedOsx1+ osteoblasts (Bmp2F/F;
Osx1-GFP::Cre or Bmp2Osx1Δ/Δ) using the Osx1-GFP::Cre
transgene (Rodda and McMahon, 2006). BMSCs were cultured in
osteogenic medium with BMP2, Wnt3a or BMP2 plus Wnt3a.
Alizarin Red staining revealed that Bmp2F/F cells had partially
mineralized their matrix; this was enhanced by treatment with either
BMP2 or Wnt3a; and mineralization was maximized by dual
exposure to BMP2 plus Wnt3a (Fig. 5A, left panels and B).
Bmp2Osx1Δ/Δ cells produced comparable levels of mineralized
matrix under each corresponding culture condition, including after
Wnt3a exposure (Fig. 5A, right panels and B). QPCR analysis on
RNA from day 7 confirmed that Osx1-Cre had successfully
recombined Bmp2 in Bmp2Osx1Δ/Δ cells (Fig. 5C). Furthermore,
Prx1, Runx2, Osx1, Dlx3 and Dlx5 levels were indistinguishable
between Bmp2F/F and Bmp2Osx1Δ/Δ cells for each condition
(Fig. 5D). And, consistent with results from Alizarin Red
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Fig. 3. Microarray analysis reveals that Bmp2F/F or Bmp2; Prx1-Cre cells produce a differential gene expression signature when stimulated with
Wnt3a. Primary BMSCs were differentiated in osteogenic medium (OM) plus Wnt3a. Cultures were performed in biological triplicates using pooled cells from
n=3 Bmp2F/F or n=4 Bmp2Prx1Δ/Δ mice. RNA was harvested on day 7 and analyzed by microarray. (A) Hierarchical cluster analysis comparing the 5000 most
differentially regulated genes. (B) Volcano plot where gene expression is calculated as linear fold change relative to Bmp2Prx1Δ/Δ cells treated with Wnt3a,
and P-value is calculated by one-way between-subject ANOVA for unpaired samples. Blue data points represent genes expressed >2-fold less and
red data points represent genes expressed >2-fold more in Bmp2F/F versus Bmp2Prx1Δ/Δ, where P<0.05. (C) Genomic distribution of differentially regulated
genes is displayed relative to chromosomal location. (D) WikiPathway analysis identified pathways with at least two genes exhibiting a ≥2-fold change
in expression with P≤0.05.
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staining, we found that Bmp2Osx1Δ/Δ cells are able to induce genes
required for synthesis of mineralized bone matrix includingCol1a1,
Alpl, Phospho1, Car3 and Car12 (Fig. 5E).
Grainyhead-like 3 is a novel transcription factor in the
osteoblast lineage that acts upstream of Osx1 in a BMP2-
dependent manner
We next investigated whether Grhl3 plays a role in osteoblast cell
specification. To test if Grhl3 was sufficient to regulate osteoblast cell
fate specification, we monitored specification of Osx1+ cells in
MLB13WT or MLB13kdBmp2 cells transfected with human GRHL3.
Immunoblot analysis showed that GRHL3 protein abundance is
dramatically reduced by knockdown of Bmp2 and enhanced by
rBMP2. Canonical Wnt3a or Wnt10b had no effect on GRHL3
protein expression, alone or in combination with BMP2 (Fig. 6A).
Although a longer stimulation period was required (>3 days) than in
experiments in BMSCs, Osx1 expression could be increased by
treatment with Wnt3a or Wnt10b in MLB13WT but not
MLB13kdBmp2 cells, which expressed 20-times lower levels of
Osx1 than MLB13WT (Fig. 6B). Strikingly, GRHL3 did not rescue
the ability ofWnt3a orWnt10b to induceOsx1 inMLB13kdBmp2 cells
(Fig. 6B), but induced Osx1 to levels indistinguishable from that of
WT cells when expressed in the presence of rBMP2 (Fig. 6B).
Ectopic expression of GRHL3 had minimal effects onDlx3 andDlx5
that did not correlate with specification of Osx1+ cell phenotype (not
shown). Importantly, different classes of cWnt ligands and
antagonists bind distinct extracellular domains of Lrp5/6 (Bourhis
et al., 2011; Gong et al., 2010); however, Wnt3a and Wnt10b had
similar inhibitory effects on Bmp2-deficient cells.
To test if Grhl3 was necessary for osteoblast differentiation, we
monitored specification of Osx1+ cell fate in MLB13WT cells
transfected with siRNAs targetingGrhl3 (Fig. 6D). We also knocked
down the highly conserved family memberGrhl2 (Fig. 6C) since it is
expressed in our cell models, can heterodimerize with Grhl3 (Ting
et al., 2003b) and has been shown to compensate for Grhl3 during
wound repair in skin (Boglev et al., 2011). Following knockdown, we
stimulated cells for 48 h with BMP2, Wnt3a or BMP2+Wnt3a and
then performed QPCR. Suppression of Grhl3 resulted in a
Table 1. Summary of microarray data assessing expression of genes in
the BMP signaling pathway in Bmp2F/F or Bmp2Prx1Δ/Δ cells treated with
Wnt3a
Gene
Fold change
Bmp2F/F+Wnt3a
vs Bmp2F/F)
P-value
(ANOVA,
unpaired)
Fold change
(Bmp2Prx1Δ/Δ
+Wnt3a vs Bmp2F/F
+Wnt3a)
P-value
(ANOVA,
unpaired)
Bmp2 2.64 0.002 −2.16 0.026
Bmp3 1.4 0.007 1.03 0.963
Bmp4 1.18 0.043 −1.17 0.515
Bmp5 1.05 0.495 −1.61 0.007
Bmp6 1.03 0.854 −1.13 0.459
Bmp7 1.01 0.894 −1.21 0.009
Bmp8b 1.02 0.796 1 0.886
Bmp10 1.1 0.181 −1.14 0.071
Gdf1 −1.02 0.606 −1.02 0.621
Gdf2 −1.09 0.006 −1.17 0.016
Gdf3 1.49 0.083 1.12 0.903
Gdf5 −1.02 0.747 1.05 0.606
Gdf6 2.5 0.175 2.35 0.006
Gdf7 1.4 0.044 2.44 0.0002
Gdf9 1.01 0.576 −1.03 0.109
Gdf10 1.04 0.642 −1.11 0.152
Gdf15 1.23 0.074 −1.26 0.069
Gdf11 1.11 0.296 −1.04 0.277
Bmpr1a −1.12 0.077 −1.16 0.103
Bmpr1b 1.05 0.326 1.15 0.087
Bmpr2 1.16 0.098 −1.06 0.389
Acvr2a 1.25 0.176 −1.02 0.164
Acvr2b 1.07 0.879 −1.06 0.460
Noggin −1.45 0.011 −1.38 0.11
Grem1 3.03 0.008 −1.22 0.144
Grem2 2.62 0.0004 1.59 0.004
Smad1 −1.32 0.212 1.07 0.684
Smad2 1.05 0.035 1.14 0.013
Smad3 1.1 0.395 1.17 0.243
Smad4 1.05 0.169 1 0.501
Smad5 1.13 0.301 −1.03 0.404
Smad6 −1.3 0.124 −2.32 0.004
Smad7 1.46 0.014 −1.22 0.425
Smad8 −1.37 0.437 −3.06 0.006
Id1 1.27 0.317 −2.00 0.003
Id3 1.21 0.126 −2.01 0.002
Gene expression is reported as linear fold change, with N=3 samples per
group, and P-value was calculated by one-way between-subject ANOVA for
unpaired samples. Red text indicates BMP signaling response genes.
Table 2. Summary of microarray data assessing expression of genes in
the Wnt signaling pathway in Bmp2F/F or Bmp2Prx1Δ/Δ cells treated with
Wnt3a
Gene
Fold change
(Bmp2F/F
+Wnt3a vs
Bmp2F/F)
P-value
(ANOVA,
unpaired)
Fold change
(Bmp2Prx1Δ/Δ
+Wnt3a vs Bmp2F/F
+Wnt3a)
P-value
(ANOVA,
unpaired)
Wnt2 1.06 0.669 −1.18 0.232
Wnt2b 1.07 0.348 1.02 0.506
Wnt3 1.09 0.224 −1.09 0.053
Wnt3a 1.05 0.356 −1.01 0.341
Wnt4 1.38 0.092 −1.78 0.001
Wnt5a 1.06 0.565 1.05 0.883
Wnt5b −1.13 0.367 −1.09 0.024
Wnt6 1.1 0.213 −1.08 0.054
Wnt7a −1.09 0.553 −1.1 0.164
Wnt7b 3.22 0.010 1.56 0.125
Wnt8a −1.14 0.279 −1.09 0.269
Wnt9a 1.15 0.090 1.26 0.003
Wnt9b 1.15 0.160 −1.29 0.007
Wnt10a −1.06 0.145 −1.07 0.013
Wnt10b 1.31 0.069 −1.33 0.071
Wnt11 1.09 0.565 −1.01 0.356
Wnt16 1.09 0.401 −1 0.850
Lrp4 −1.05 0.759 −2.85 0.011
Lrp5 −1.57 0.030 1.33 0.006
Lrp6 1.02 0.270 1.03 0.533
Rnf43 1.4 0.018 −1.22 0.358
Znf43 NR −1.11 0.167
Lgr4 −1.37 0.145 1.00 0.978
Lgr5 1.64 0.129 6.42 0.0001
Lgr6 1.05 0.868 −2.54 0.003
Dkk1 −4.13 0.002 −1.11 0.99
Sost 1.14 0.867 −1.31 0.142
Notum 1.3 0.263 −4.27 0.002
Wif1 −1.02 0.971 −3.91 0.058
Frzb −3.94 0.102 −1.66 0.193
Sfrp1 −2.71 0.009 1.21 0.049
Sfrp2 1.5 0.181 3.51 0.0002
Sfrp4 1.73 0.004 −1.13 0.384
Sfrp5 1.01 0.551 −1.05 0.185
Ctnnb1 −1.03 0.150 −1.02 0.126
Axin2 2.10 0.005 1.14 0.069
Gene expression is reported as linear fold change, with N=3 samples per
group, and P−value was calculated by one-way between-subject ANOVA for
unpaired samples. Red text indicates a Wnt signaling response gene.
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statistically significant though modest decrease in the abundance of
Prx1, Runx2, Dlx3 and Dlx5 mRNAs expressed in BMP2 treated
cells (Fig. 6E-H, red and black bars). Modest upregulation ofPrx1 by
BMP2 was also blunted by suppression of Grhl2 (Fig. 6E). As seen
previously, BMP2 treatment led to high magnitude upregulation of
Osx1 and Alpl (45 and 20-fold, respectively), and this upregulation
was blunted by 50-80% by introduction of Grhl2 and/or Grhl3
siRNAs (Fig. 6I,J). Grhl3 siRNA also completely abrogated the
induction of Car12 by BMP2 (Fig. 6K). Expression of Col1a1 and
Phospho1 were modestly reduced by Grhl3 siRNAs (Fig. 6L,M).
By contrast,Car3 expression in response toWnt3a greatly increased
following suppression of Grhl2 (Fig. 6N), consistent with the fact
that Grhl proteins are Janus factors and can therefore act as
transcriptional activators or repressors at different genetic loci.
Moreover, Grhl2 and Grhl3 siRNAs did not cause a non-specific
decrease in global gene expression. These cumulative results
strongly suggest that Grhl2 and Grhl3 are both necessary and
sufficient for the mechanism by which BMP2 specifies progenitors
to an Osx1+ osteoblast cell fate. Comprehensive statistical analysis
is provided in Table S1.
Grhl3 is expressed during endochondral skeletal
development and is induced during bone repair
Previous reports suggest Grhl3 is expressed in the condensing limb
bud mesenchyme of E13.5 mouse embryos (Kudryavtseva et al.,
2003), consistent with our findings that Grhl3 is expressed in E13.5
mouse limb bud cells. Consultation with the Eurexpress.org in situ
hybridization database revealed that mRNAs for Grhl3 are enriched
in the perichondrium of developing endochondral structures in the
E14.5 hindlimb (Fig. 7A,B), where the expression domain of Grhl3
overlaps with Lrp5 and Bmp2 (Fig. 7C,D). In situ hybridization on
E16.5 hindlimb and forelimb indicates Grhl3 expression is evident
in the developing bone collar, hypertrophic chondrocytes, and cells
within the newly forming subchondral bone (Fig. 7E). This Grhl3
expression domain corresponds to regions where newly forming
osteoblasts appear during development (Salazar et al., 2016) and
moreover, where Bmp2 is expressed when monitored using a
Bmp2ki(lacZ) gene replacement allele (Fig. 7F). Finally, we created
standardized fractures in adult mouse femurs to monitor Grhl3 (and
microarray hits) in an in vivomodel of bone formation that relies on
endogenous BMP2 and cWnt signaling mechanisms (Chen et al.,
2007; Tsuji et al., 2006). QPCR analysis revealed that Bmp2,
signaling molecules of the cWnt pathway, Grhl2 and Grhl3
continue to be expressed in marrow-free bone tissue in the adult
skeleton (Fig. 7G,H). Bmp2 and cWnt signaling molecules, as well
as surrogate markers of BMP signaling (Id3) and Wnt signaling
(Axin2) were robustly induced 5 days following fracture (Fig. 7G).
These endogenous signaling dynamics characteristic of early
endochondral bone repair were accompanied by no changes in
Grhl2, a modest increase in Runx2, and striking inductions of Prx1,
Osx1 and Grhl3 (Fig. 7H). Car3, Car12, Alpl and Phospho1 were
also induced at the fracture site (Fig. 7I), providing evidence that
the molecular targets identified by microarray analysis in primary
cells are biologically significant for osteoblast physiology during
bone repair.
DISCUSSION
We used multiple mouse and primary cell models to test whether
BMP and cWnt signaling play unique or redundant roles in the
specification of new osteoblasts and subsequent production of bone
matrix.Among themanyBMPs expressed in bone, our data revealed a
specific requirement for BMP2 in progression of Prx1+ progenitors
through the Runx2/Osx1 transition. We identified Grhl3 as a
Table 3. Summary of microarray data assessing expression of genes
involved in endochondral ossification in Bmp2F/F or Bmp2Prx1Δ/Δ cells
treated with Wnt3a
Gene
Fold change
(Bmp2F/F
+Wnt3a vs
Bmp2F/F)
P-value
(ANOVA,
unpaired)
Fold change
(Bmp2Prx1Δ/Δ
+Wnt3a vs
Bmp2F/F+Wnt3a)
P-value
(ANOVA,
unpaired)
Sox2 −1.02 0.660 −1.02 0.819
Nes 1.19 0.085 −1.08 0.225
Lepr 1.45 0.221 −2.33 0.078
Pdgfra −1.85 0.007 −1.38 0.114
Prrx1 1.16 0.018 −1.01 0.310
Msx2 1.07 0.453 −1.08 0.228
Dermo1 −1.16 0.699 −1.09 0.819
Runx2 1.15 0.441 −1.28 0.490
Grhl3 2.55 0.034 −5.57 0.007
Osx1 −1.00 0.660 −2.89 0.038
Dlx1 −1.08 0.705 −1.17 0.020
Dlx2 1.55 0.102 −1.75 0.005
Dlx3 −1.61 0.078 −2.14 0.012
Dlx4 1.04 0.354 −1.11 0.083
Dlx5 −1.07 0.512 −1.93 0.025
Dlx6 −1.11 0.312 −1.46 0.015
Sox9 −1.09 0.516 −1.74 0.001
Mef2c −1.15 0.199 −2.12 0.017
Ihh 1.2 0.439 −1.92 0.001
Ptch1 1.33 0.125 −2.37 0.033
Gene expression is reported as linear fold change, with N=3 samples per
group, and P-value was calculated by one-way between-subject ANOVA for
unpaired samples. Red text indicates differentially regulated transcription
factors that affect endochondral lineages.
Table 4. Summary of microarray data assessing expression of genes
involved in mineral metabolism in Bmp2F/F or Bmp2Prx1Δ/Δ cells treated
with Wnt3a
Gene
Fold change
(Bmp2F/F
+Wnt3a vs
Bmp2F/F)
P-value
(ANOVA,
unpaired)
Fold change
(Bmp2Prx1Δ/Δ
+Wnt3a vs
Bmp2F/F+Wnt3a)
P-value
(ANOVA,
unpaired)
Alpl −1.12 0.088 −1.91 0.041
Phospho1 −1.18 0.231 −2.44 0.045
Car1 1.08 0.300 −1.07 0.143
Car2 −1.56 0.157 −1.26 0.202
Car3 −1.16 0.745 −13.24 0.011
Car4 1.04 0.717 −1.2 0.453
Car5a −1.12 0.147 −1.13 0.016
Car5b −1.06 0.762 1.24 0.029
Car6 1.16 0.510 −1.28 0.068
Car7 1.13 0.401 −1.02 0.797
Car8 2.21 0.008 −1.77 0.0001
Car9 −1.14 0.182 −1.27 0.019
Car10 −1.03 0.565 −1.07 0.916
Car11 −1.1 0.119 −1.24 0.132
Car12 −3.2 0.164 −12.35 0.019
Car13 −1.01 0.850 1.09 0.301
Car14 −1.03 0.359 1 0.868
Car15 1.11 0.021 −1.03 0.339
Enpp1 1.05 0.436 −1.05 0.178
Mepe −1.5 0.0006 −1.01 0.683
Phex −4.14 0.022 −1.68 0.185
Dmp1 −1.64 0.238 −3.86 0.028
Gene expression is reported as linear fold change, with N=3 samples per
group, and P-value was calculated by one-way between-subject ANOVA for
unpaired samples. Red text indicates differentially regulated genes with
potentially significant impact on biomineralization.
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Fig. 4. Conditional ablation of Bmp2 in the Prx1+ lineage disrupts the Runx2/Osx1 transition, mineral metabolism and upregulation of Grhl3. Primary
BMSCs were differentiated in osteogenic medium (OM) plus growth factors. Cultures were performed in biological triplicates using pooled cells from n=3 Bmp2F/F
or n=4 Bmp2Prx1Δ/Δ mice. QPCR on day 7 monitored expression of targets identified with microarray analysis, reported as mean±s.d. aP<0.05 vs Bmp2F/F+OM,
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novel transcription factor in the osteoblast lineage that contributes to
specification of an Osx1+ cell fate in a BMP-dependent
manner. These essential functions for BMP2 were enhanced by but
not compensated for by cWnt activity in our primary cell model
systems. We are currently completing a rigorous study of these
findings in vivo.
Themarrow and periosteum of adult bone provide essential niches
for skeletal stem cells (Chan et al., 2015; Worthley et al., 2015) and
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other fate-restricted skeletal progenitors (Mizoguchi et al., 2014;
Ono et al., 2014; Zhou et al., 2014) that give rise to new osteoblasts
for bone growth and repair during postnatal life (Kassem andBianco,
2015; Kfoury and Scadden, 2015). Skeletal stem cells (SSCs) first
appear in the limb bud mesenchyme, where Prx1 is broadly
expressed, and upon residency in adult bone, produce a variety of
secreted niche factors including Bmp2, Wnt3a, TGFβ3 and Grem1
(Chan et al., 2015; Worthley et al., 2015; Yang et al., 2013).
Accumulating data suggest that specific skeletal tissue types, such as
bone or cartilage, can be induced from SSCs as well as ESCs (Craft
et al., 2013) by controlling the timing and combination of growth
factors presented to the cell. Understanding howeach of these growth
factors contributes, either alone or in combination, to a particular
skeletogenic milieu has therefore emerged as a crucial step in
understanding how to modulate bone mass or bone repair in humans
with skeletal trauma or disease. The primary BMSC preparations
used in this study expressedPrx1, Lepr,Nes,Pdgfra andGrem1, and
therefore likely represent a heterogeneous population containing key
skeletal progenitors identified in these recent studies. Of these
markers, only Leprwas differentially expressed inBmp2Prx1Δ/Δ cells.
Future studies will shed light on whether BMP2 regulates the
expression of Lepr and/or abundance of Lepr+ progenitors.
Here, we focused on understanding how BMP2 accomplishes
transcriptional control of osteoblast differentiation fromendochondral
progenitors. Bmp2Prx1Δ/Δ cells successfully expressed transcriptional
mediators of early endochondral bone formation including Sox2,
Hand2,Msx2,Prx1,Dermo1 andRunx2.However,Bmp2Prx1Δ/Δ cells
expressed very low levels of late transcriptional mediators including
Dlx3, Dlx5 and Osx1, a group of proteins that heterodimerize to
induce genes essential for the physiology of mature osteoblasts (Hojo
et al., 2016). These data revealed a block in theRunx2/Osx1 transition,
consistent with the fact that Osx1 was originally cloned as a BMP2-
responsive gene (Nakashima et al., 2002). Importantly, however,
Osx1 expression is highly enriched in the skeleton and is therefore not
indiscriminately expressed in all tissues undergoing active BMP
signaling. We thus hypothesized that additional co-factors are
required to target a BMP transcriptional response to the Osx1
promoter during osteoblast differentiation.We focused onDlx3,Dlx5
and Grhl3, since microarray analysis indicated these were highly
altered transcription factor genes in our samples. Since BMP2 is able
to induceOsx1 in cells lackingRunx2 but not lackingDlx5 (Lee et al.,
2003; Ulsamer et al., 2008), we used Ensembl to search 13 kb of the
murineOsx1promoter for predictedDlx bindingmotifs. Interestingly,
we did not find Dlx3/5 binding sites, but did identify 12 predicted
binding sites for Grhl3 intermingled with numerous Smad binding
motifs (Gordon et al., 2014; Harrison et al., 2010).
We also found that Grhl3 is induced at the transcriptional level by
cWnt signaling, and is regulated at the protein level by BMP2
signaling via as yet undefined mechanisms. Plasmid-based
expression of GRHL3 specified Osx1+ cell fate of limb bud
progenitors in a BMP2-dependent and Wnt3a-independent manner,
while suppression of Grhl3 impaired the ability of BMP2 to induce
Osx1. In vivo gene expression studies revealed that Grhl3 is co-
expressed in regions where BMP and cWnt signaling contribute to
bone development and bone repair. Grhl3 is therefore expressed at
the appropriate time and place to be involved in developmental
skeletogenesis and fracture repair. Our data strongly suggest that
Grhl2 and Grhl3 play a necessary and sufficient role in the
formation of Osx1+ cells. Importantly, these collective findings
reconcile with a requirement for both BMP and cWnt/β-catenin
signaling during specification of Osx1+ cells during skeletal
development (Bandyopadhyay et al., 2006; Day et al., 2005; Hill
et al., 2005). We are currently utilizing in vivo systems to evaluate
Grhl3 as a potential nexus by which BMP2 and cWnt signaling
cooperate to drive bone formation and bone repair in vivo. Further
work is also needed to formally test the role of Grhl3 (and potential
compensation by Grhl1 and Grhl2) in skeletal development.
A variety of human, mouse and fish studies suggest reduced
expression of Grhl3, Dlx3, Dlx5 and Osx1 could explain the defects
we found in calcium and phosphate metabolism (Dworkin et al.,
2014; Han et al., 2011; Isaac et al., 2014; Lapunzina et al., 2010; Liu
et al., 2015; Nguyen et al., 2013; Ting et al., 2003a). Mineralization
of the endochondral skeleton is a complex biological process
involving the formation of a calcium phosphate hydroxyapatite
crystal that is deposited into an organic extracellularmatrix composed
primarily of type I collagen. Carbonic anhydrases (CAs) are zinc-
dependent metalloenzymes that catalyze the hydration of carbon.
Whereas inmammals, CAs are best known for their role in processing
metabolic waste, regulating pH and fixing carbon, paleogenomic
studies in sponges suggest that the ancestral CA was one of the first
genes to confer the ability to synthesize skeletogenic structures
through the formation of calcium carbonate (Jackson et al., 2007) and
recent evidence suggests that calcium carbonate is an essential
precursor crystal to the mature calcium phosphate hydroxyapatite
crystals comprising endochondral bone (Müller et al., 2013).
Although additional work clarifying the role of CA enzymes in
bone metabolism is needed, we find that Car3 and Car12 are locally
induced in bone following fracture.
In summary, we identify pre-Osx1+ progenitors as a crucial
source and target of endogenous BMP2 required for the Runx2/
Osx1 transition and show that BMP2 and cWnt play cooperative but
non-redundant roles during osteoblast cell fate specification.
MATERIALS AND METHODS
Animals
In vivo experiments were performed in compliance with the Guide for the
Care and Use of Laboratory Animals and were approved by the Harvard
Medical Area Institutional Animal Care and Use Committee (protocol
#04043 to V.R.). Mice carrying floxed Bmp2 alleles (Bmp2F/F) were bred to
Prx1-cremice (Logan et al., 2002) orOsx1-cremice (Rodda andMcMahon,
2006) to obtain Bmp2F/F; Prx1-Cre mice (Bmp2Prx1Δ/Δ) or Bmp2F/F; Osx1-
EGFP::Cre mice (Bmp2Osx1Δ/Δ).
Standardized fractures
Standardized fractures with pin stabilization were made in femora of adult
mice as previously described (Tsuji et al., 2006). Fractured and non-
fractured contralateral controls femurs were collected 5 days post fracture
and 6 mm of mid diaphysis bone were dissected, cleaned of bone marrow,
snap frozen in liquid nitrogen, and processed for total RNA extraction
according using Trizol and RNeasy Plus kit, as previously described
(Salazar et al., 2013).
Cell culture
MLB13 cells were prepared from immortalized limb bud cells from E13.5
mouse embryos (MLB13 clone14) (Rosen et al., 1993, 1994) cultured and
Fig. 6. Grainyhead-like 3 (Grhl3) is a novel transcription factor that acts
upstream of Osx1 during osteoblast differentiation. (A) Immunoblot and
(B) QPCR analysis on MLB13WT or MLB13kdBmp2 cells expressing human
GRHL3 with an N-terminal V5-tag and stimulated for 3 days with indicated
ligands (+ indicates presence of ligand for each lane). Error bars represent s.d.
of biological triplicates. Immunoblot shows cells expressing human
V5-GRHL3. Similar results were obtained using human GRHL3-V5.
(C-N) QPCR analysis on MLB13WT cells, transfected with siRNA targeting
mouse Grhl2, Grhl3, or Grhl2 and Grhl3. Comprehensive statistical analysis
provided in Table S1. n.s., not significant.
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maintained in DMEM supplemented with 10% fetal bovine serum and
100 U/ml penicillin-G and 100 mg/ml streptomycin. Cells are
contamination free and were authenticated by neomycin resistance, which
was conferred during immortalization. MLB13 cells were transfected with
Bmp2-shRNA plasmid [BLOCK-iT, Invitrogen (5′-TGCTGAGTTCAAG-
AA-GTCTCCAGCCAGTTTTG-GCCACTGACTGACTGG-CTGGACT-
TCTTGAACT-3′)] using Lipofectamine 2000 (Invitrogen), selected for
3 weeks in 20 mg/ml blasticidin S and cloned by limiting dilution. Where
indicated, cells were seeded to confluence and pretreated with
cycloheximide (Sigma Aldrich, diluted to 25-100 mg/ml in growth
medium) for 1 h prior to 4 h stimulation with Wnt3a+cyclohexamide.
BMSCs were prepared from bone marrow from 4- to 6-month-old mice
(male and female) collected as previously described (Salazar et al., 2013) and
plated in BMSC medium [ascorbic acid-free α-MEM (Invitrogen) containing
20% FBS, 40 mM L-glutamine, 100 U/ml penicillin-G and 100 mg/ml
streptomycin]. After 3 days, non-adherent cells were removed by vigorous
washing. Forosteoblast differentiation,BMSCswere seeded inBMSCmedium
at 35,000 cells/well in 96-well dishes (for Alizarin Red staining) or 300,000
cells per well in 24-well dishes (for RNA or protein). Confluent cultures were
stimulated on day 1 with osteogenic medium (OM: BMSC medium plus
50 μg/ml ascorbic acid and 10 mM β-glycerophosphate) and recombinant
proteins.
Recombinant proteins were added as indicated to culture medium: human
BMP2 (200 ng/ml; Genetics Institute), and mouse Wnt3a and Wnt10
(40 ng/ml; R&D Systems).
QPCR
Total RNAwas harvested according to the manufacturer’s instructions using
the RNeasy Plus Kit (Qiagen). RNA was reverse transcribed with EcoDry
Premix (Clontech). Data were normalized to β-actin, analyzed using the
ΔΔCTmethod, and expressed as mean±s.d. (when biological replicates were
established with pooled cells from multiple mice) or mean±s.e.m. (when
biological replicates were established from unpooled cells from multiple
mice) relative to Bmp2F/F cells cultured in osteogenic medium. Student’s
t-test was utilized to calculate P-values.
Alkaline phosphatase biochemical assay
Cells were plated at 2×104 cells/well in 96-well dishes, stimulated with
Wnt3a for 3 days, fixed in acetone/ethanol (50:50), and incubated with a
substrate solution composed of 0.1 M diethanolamine, 1 mM MgCl2 and
1 mg/ml p-nitrophenylphosphate. The reaction was quenched with 3 M
NaOH and absorbance measured at 405 nm.
Plasmids and siRNAs
Human GRHL3 plasmid was provided by the Center for Cancer Systems
Biology, PlasmID clone HsCD00376192. MLB13 cells were seeded to 90%
confluence, transfected with a plasmid encoding human GRHL3, and then
cultured for 3 days in osteogenic medium plus indicated growth factors.
Cells were seeded 200K cells/well in a 24-well dish and transfected
according manufacturer’s directions using RNAiMax (Invitrogen) and
10 pmol of indicated siRNA. Cells were stimulated 48 h with osteogenic
medium with or without BMP2 and Wnt3a or with BMP2+Wnt3a.
Adenovirus infection
Ad5-CMV-eGFP and Ad5-CMV-Cre-ires-eGFP viral particles were
obtained from the University of Iowa Gene Transfer Vector Core.
BMSCs were seeded at 40,000 cells/well in 96-well dishes for
mineralization assays or 400,000 cells/well in 24-well dishes for QPCR,
transduced for 6 h with 100 m.o.i of virus and 25 mM Hoechst in ascorbic
acid-free α-MEM containing 2% FBS and L-glutamine, penicillin and
streptomycin as for cell culture methods above. Cells recovered overnight
in BMSC medium.
Histology
Cells were fixed 10 min in 10% neutral buffered formalin before staining
with 1 mg Napthol AS-MX phosphate in 25 ml N,N-dimethylformamide
plus 6 mg Fast Blue RR salt in 10 ml of buffer consisting of 0.1 M Tris-
Base, 2 mM MgCl2, pH 8.5.
For Alizarin Red staining, fixed cells were stained for 30 min in 0.4%
aqueous solution of Alizarin Red S (Sigma). Alizarin Red S was eluted in
10% glacial acetic acid, pH was adjusted with 10% ammonium hydroxide,
and absorbance measured at 405 nm.
Immunoblotting
Cells were scraped into RIPA buffer containing Halt protease and
phosphatase inhibitors (Pierce) and homogenized with a QiaShredder
column (Qiagen). Proteins were separated by SDS-page electrophoresis and
immunoblotted with the following antibodies at 1:1000 dilution: p-Smad1/5
(Cell Signaling, 9511), p-Smad2/3 (Cell Signaling, 3101), β-catenin C-
terminus (BD 61054), β-catenin N-terminus (Cell Signaling, 9562), osterix
(Abcam, ab22552), V5 (Invitrogen, R961-25) and α-tubulin (Sigma,
T6074).
Microarray analysis
Gene-level differential expression analysis was performed with Affymetrix
Mouse ST 2.1 microarrays on BMSCs from Bmp2F/F or Bmp2Prx1Δ/Δ mice
differentiated for 7 days with osteogenic medium alone or in medium plus
BMP2 (100 ng/ml), Wnt3a (40 ng/ml) or both. Cultures were performed in
biological triplicates using pooled cells from n≥3 mice/genotype. Eight
cDNA libraries were made from 100 ng total RNA usingWTExpression Kit
(Ambion): one pooled sample from three independent cultures of Bmp2F/F
cells grown in osteogenic medium (33.33 ng each) or Bmp2Prx1Δ/Δ cells with
BMP2+Wnt3a (33.33 ng each); three samples from three independent
cultures of Bmp2F/F or Bmp2Prx1Δ/Δ cells with Wnt3a. Data were analyzed
with Expression Console and Transcriptome Analysis Console v.3.0
(Affymetrix). Gene expression was reported as linear fold change relative
to Bmp2Prx1Δ/Δ cells with Wnt3a, and P-values were calculated by one-way
between-subject ANOVA for unpaired samples.
In situ hybridization and localization studies
E16 mouse embryo hindlimbs were fixed, paraffin processed and sectioned
in the sagittal plane using standard methods. In vitro transcription to
generate riboprobes was performed using standard protocols and reagents
(Promega). In situ hybridization with digoxigenin-labeled Grhl3 probe
(kindly provided by Stephen Jane, Monash University, Australia) was
carried out as described previously (Gamer et al., 2009). Hindlimbs from
E16 mice were embedded in optimal cutting temperature compound (OCT)
on dry ice and frozen sections were prepared for β-galactosidase staining as
previously described (Kokabu et al., 2012).
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